Navigation Links
Misonix Schedules First Quarter Fiscal Year 2009 Financial Results Conference Call; November 13, 2008 at 4:30 P.M. Eastern
Date:11/11/2008

FARMINGDALE, N.Y., Nov. 11 /PRNewswire-FirstCall/ --Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, today announced plans to release first quarter fiscal year 2009 financial results on Thursday afternoon, November 13, 2008. Michael A. McManus, President and Chief Executive Officer and Richard Zaremba, Senior VP and Chief Financial Officer, will host a conference call at 4:30 p.m. Eastern on Thursday, November 13, 2008 to discuss the Company's first quarter fiscal 2009 financial results.

Shareholders and other interested parties may participate in the conference call by dialing (866) 788-0543 (domestic) or (857) 350-1681 (international) and entering access code 21386797, a few minutes before the start of the call. A simultaneous webcast will be available via Misonix's website at http://www.misonix.com. The call will be archived on the Company's website for at least 90 days.

A recording of the live-call will be available approximately 2 hours after the event through November 20, 2008. The dial-in number to listen to the recording is (888) 286 8010 or (617) 801 6888. The replay access code is 80767628.

About Misonix:

Misonix, Inc. (NASDAQ: MSON) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platfor
'/>"/>

SOURCE Misonix, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
2. Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference
3. GNC Schedules Conference Call and Webcast to Report 3rd Quarter 2008 Financial Results
4. NeoGenomics Schedules Its Q3 2008 Earnings Release for November 6, 2008
5. Chem Rx Corporation Schedules 2008 Annual Meeting Date
6. SCOLR Pharma, Inc. Schedules Third Quarter 2008 Financial Results Conference Call for November 7, 2008 at 11:30 A.M. Eastern
7. Birner Dental Management Services, Inc. Schedules Earnings Call to Discuss Third Quarter 2008 Results
8. MiddleBrook Pharmaceuticals Schedules Conference Call and Webcast for Third Quarter 2008 Financial Results
9. The Ensign Group Schedules 2008 Third Quarter Earnings Call for Friday, October 31, 2008
10. VirtualScopics Schedules Third Quarter 2008 Earnings Announcement
11. Varian Medical Systems Schedules Fiscal Year End Review in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... NC (PRWEB) , ... September 04, 2015 , ... ... the Consumer Health Products Association (CHPA) joint meeting of its Product, Quality and ... for hazardous waste handling rules constantly evolving in the consumer goods industry, it ...
(Date:9/4/2015)... San Francisco, CA (PRWEB) , ... September 04, ... ... Ben Amini, announces that CEREC technology is now available at CitiDent. CEREC is ... milling machinery. In addition to saving time for patients by eliminating the need ...
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, ... devices, announced its only mission and research focus: Water Life Science®. In the ... body water evaporation is becoming dangerously accelerated. As a result of the global ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... its first neighborhood created specifically for adults with intellectual, developmental and acquired disabilities. ... area and feature 30 cottage or “pocket” homes. In this community, adults will ...
(Date:9/4/2015)... ... ... Pastor and Overseer at The House of Yahweh, has written an open letter to Pope ... the United States. , Yisrayl lays out what he says is the true meaning of ... also provides the meaning of his own name and describes what bible prophecy says about ...
Breaking Medicine News(10 mins):Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
... Nestled in the heart of one of the most ... (HPMC) is reaching out to families throughout the city with ... a place that is comfortable and secure, night and day, ... based on the simple principle of trust," said Jim Banahan, ...
... to Launch in U.S. Next Month -CHICAGO, April 27 ... Association,s (AUA) Annual Conference show that GELNIQUE(TM) (oxybutynin chloride) ... urge incontinence in women with the condition. By ... of women treated with GELNIQUE achieved complete urinary continence ...
... Wis., April 27 Compirion Healthcare ... firm concentrating on whole hospital improvement, is proud ... President of Business Development and Operations.According to Compirion ... Operational Effectiveness, Bill has developed and implemented operational ...
... proper prescribing , , MONDAY, April 27 (HealthDay News) -- ... dollars each year in the United States, but two ... to reduce these mistakes. , Medication errors are one ... 1.5 million people every year and costing the health-care ...
... and the RAND Corp. has found that perceived racial ... fifth-grade students and that it may have a negative ... Study results show that 15 percent of children surveyed ... the vast majority of these encounters occurred at school. ...
... More than 3,000 long-term care professionals are meeting ... largest gathering of personnel from skilled nursing facilities, assisted ... The Ohio Health Care Association (OHCA), which represents nearly ... is hosting its 63rd Annual Convention & Exhibition at ...
Cached Medicine News:Health News:Hollywood Presbyterian Medical Center: Taking the Message of Trust to the Streets of LA 2Health News:New Data Presented at AUA's Annual Conference Prove GELNIQUE(TM) (oxybutynin chloride) 10% gel is an Effective, Safe Option for Female Overactive Bladder (OAB) Patients 2Health News:New Data Presented at AUA's Annual Conference Prove GELNIQUE(TM) (oxybutynin chloride) 10% gel is an Effective, Safe Option for Female Overactive Bladder (OAB) Patients 3Health News:New Data Presented at AUA's Annual Conference Prove GELNIQUE(TM) (oxybutynin chloride) 10% gel is an Effective, Safe Option for Female Overactive Bladder (OAB) Patients 4Health News:Compirion Heathcare Solutions Hires Senior Vice President Business Development/Operations 2Health News:Medication Errors Could Be Cut: Experts 2Health News:Medication Errors Could Be Cut: Experts 3Health News:Medication Errors Could Be Cut: Experts 4Health News:Mental health problems more common in kids who feel racial discrimination 2Health News:Ohio Health Care Association/Ohio Centers for Assisted Living Host Midwest's Largest Long-Term Care Convention in Columbus 2
(Date:9/4/2015)... Physician E-sampling is becoming well established across ... key marketing sales tactic in recent years. However, some ... a supplement to traditional sampling. According ... E-sampling has been seeded across multiple therapeutic areas- including ... has been in place for five or more years ...
(Date:9/4/2015)... 2015  Janssen Research & Development, LLC (Janssen) ... (FDA) has accepted for Priority Review the Biologics ... for patients with multiple myeloma who are refractory ... immunomodulatory agent (IMiD), or who have received three ... PI and an IMiD. This is referred to ...
(Date:9/4/2015)... , Sept. 4, 2015 Fair Rate Funding, ... Jersey , reports a dramatic increase in lawsuit filings ... of filed Xarelto lawsuits in the Philadelphia ... to over 300 cases.  In the Louisiana ... for the Eastern District of Louisiana , ...
Breaking Medicine Technology:Current and Future Trends in Physician E-Sampling Programs for the Pharmaceutical Industry 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3
... Safety and Pharmacokinetic Results in Healthy Volunteers to be Presented at ... ... (Nasdaq: ANDS ) announced today preliminary results of a Phase I,clinical trial ... trial of ANA598 in patients chronically infected,with hepatitis C virus (HCV). In the ...
... Rehovot, Israel, reported today results of its internal,clinical trial of ... cancer., In the trial a total of 76 sputum ... Healthy individuals that never smoked 2. Heavy smokers with ... cancer patients (Stage 1) 4. Advanced stage lung cancer ...
Cached Medicine Technology:Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 2Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 3Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 4Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 5Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients 6BioView Reports Interim Results of Early Detection Lung Cancer Diagnostic Test 2
... The Bile Reflux Analysis for POLYGRAM NET® ... Application. This add-on allows medical professionals to upload ... ambulatory bile reflux recorder. The primary difference is ... absorbance of a certain wavelength of light corresponding ...
Symbia T6, a True Point SPECT·CT system, combines a dual-detector variable angle gamma camera with a six slice CT scanner for advanced oncology, neurology, and cardiology applications....
... ACOM.Net is a high-efficiency network for ... data security on an expandable platform., If ... and archive DICOM 3 images in real-time ... different workstations without loss of speed, Connect ...
... the AXIOM Artis dBC Magnetic Navigation ... navigation system equipped with digital flat ... is uniquely capable of improving the ... to facilitate increased efficiency and productivity ...
Medicine Products: